PRMT6 and prostate carcinoma: We verified target silencing in HEK293T cells and in the androgen-sensitive prostate cancer cell line, LNCaP, because LSD1 and PRMT6 are overexpressed in prostate cancer and correlate with cancer aggressiveness (Fig. 9a)22,23,27.